Derek Lowe says it’s falling behind that US:
Phrases like “fair reward for innovation” and “alternative pricing and reimbursement mechanisms” point to one that might. These seem to be carefully worded calls to let the drug companies make a bit more money, in the hopes that they might find it worthwhile to make some more drugs.
Similar Posts:
- Prescription medication pay for performance, and the rationale behind it
- Should consumer prescription drug ads be reined in?
- Poll: Should doctors discuss the price of medical treatment?
KevinMD.com on Facebook
Comments on this entry are closed.